New Zealand - Re-Import of Heparin for Therapeutic Use
Since 2014, New Zealand Re-Import of Heparin for Therapeutic Use grew 60.2% year on year. At $40,139.76 in 2019, the country was ranked number 6 comparing other countries in Re-Import of Heparin for Therapeutic Use. New Zealand is overtaken by Argentina, which was number 5 with $282,142.75 and is followed by United Kingdom with $5,416.76. Canada lead the ranking with $1,738,281.5 in 2019, +72.9% versus 2018. Australia, China and France respectively ranked number 2, 3 and 4 in this ranking. Australia recorded the best 5 years average growth at +309.1% per year, while Thailand was the worst growing country at -47.1% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 40,139.76 |
| 2018 | 31,542.04 |
| 2017 | 58,903.25 |
| 2016 | 8,386.73 |
| 2015 | 100,303.80 |
Download all data from 2011 to 2019
How does New Zealand rank in Re-Import of Heparin for Therapeutic Use?
| # | 9 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Canada
|
1,738,281.50 | 2019 | +72.9 % | +112.5 % | View data | |
| 2 |
#2
Australia
|
1,253,862.50 | 2019 | +10.8 % | +309.1 % | View data | |
| 5 |
#5
Argentina
|
282,142.75 | 2019 | +110.6 % | -13.7 % | View data | |
| 6 |
#6
New Zealand
|
40,139.76 | 2019 | +27.3 % | +60.2 % | View data | |
| 7 |
#7
United Kingdom
|
5,416.76 | 2019 | -88.3 % | -13.2 % | View data | |